ANGO NASDAQ
AngioDynamics, Inc.
1W: +3.8%
1M: -21.1%
3M: -16.2%
YTD: -3.3%
1Y: -0.7%
3Y: +81.6%
5Y: -55.9%
$12.26
+0.09 (+0.74%)
Weekly Expected Move ±12.3%
$9
$11
$12
$14
$15
Credit Risk of going bust: lower than 85% of companies Debt: 2.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.9%), AngioDynamics, Inc. would be worth roughly what it owes.
Total debt $10.7M against a stock market value of $515.6M.
Distance to default 11.34 (Merton model): prices to 2026-10-27, balance sheet 2026-08-31, debt counted $1.8M (short-term plus half of long-term), stock volatility 49.4%; Altman Z 2.55. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.9%), AngioDynamics, Inc. would be worth roughly what it owes.
Total debt $10.7M against a stock market value of $515.6M.
Distance to default 11.34 (Merton model): prices to 2026-10-27, balance sheet 2026-08-31, debt counted $1.8M (short-term plus half of long-term), stock volatility 49.4%; Altman Z 2.55. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships3
As Filer
counterparties named
1
As Counterparty
mentioned by others
1
Rel. Types
2023-06-08
Earliest Filing
2024-04-01
Latest Filing
partner: 3
Counterparties (Filed by ANGO)
3 relationshipsCompanies named in ANGO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Becton, Dickinson and Company | BDX | partner | Entered into a Settlement Agreement involving mutual patent licenses and financial payments to resolve litigation. | 2024-04-01 | View |
| C.R. Bard, Inc. | BD | partner | Jointly involved in litigation and settlement agreement with AngioDynamics as part of BD. | 2024-04-01 | View |
| Bard Peripheral Vascular Inc. | BD | partner | Jointly involved in litigation and settlement agreement with AngioDynamics as part of BD. | 2024-04-01 | View |
Mentioned As Counterparty
1 mentionsOther companies that named ANGO in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-08 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-10-08 | Material Agreement; Officer/Director Change; Exhibits | Agreement | View |
| 2026-07-14 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-23 | Other Events | View | |
| 2026-04-02 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-02-03 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-14 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-06 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-11-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-10-02 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-15 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-05-28 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-04-02 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-04-02 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-01-16 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-01-08 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-01-08 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-11-15 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2024-10-03 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-07-16 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR